Skip to content

Study · Animal study (in vivo) · mouse · 2010

1 result

A kisspeptin-10 analog with greater in vivo bioactivity than kisspeptin-10.

Curtis AE, Cooke JH, Baxter JE, Parkinson JR, Bataveljic A, Ghatei MA, Bloom SR, Murphy KG

American journal of physiology. Endocrinology and metabolism24 Nov 2009Cited by 39 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Efficacy outcome

    In mice, 0.15 nmol kisspeptin‑10 had no significant effect on total testosterone 60 min after injection.

    In plain wordsIn mice, kisspeptin‑10 at 0.15 nmol did not significantly change total testosterone 60 minutes after injection.

    Outcome
    No significant changeTotal testosterone at 60 min
    Study

    mousen: not reported in source

    Mice
    Outcome group
    Sex hormones and fertility · Endocrine and hormones
    Studied dose
    0.15 nmol · peripheral · 60 min postinjectionAs given in this study (mouse).

    Measurements

    Dose
    0.15 nmol
    KP-10

    Source sentences

    Summary
    In addition, 60 min postinjection, 0.15 nmol [dY](1)KP-10 significantly increased total testosterone levels in mice whereas the same dose of KP-10 had no significant effect.
    1 context sentence
    Summary · context
    Those analogs that bound with relatively high affinity to KISS1R were tested for ability to stimulate ERK1/2 phosphorylation in vitro and for their ability to stimulate the HPG axis in vivo.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Versions 4 to 18Current

    28 Oct 2026, 02:02 UTC

    The same notice was added 15 times, first on 13 Oct 2026, 21:44 UTC. The status did not change between them.

    Study results updated

  2. Version 3

    13 Oct 2026, 16:31 UTC

    Study data updated · source update from Europe PMC

  3. Version 2

    9 Oct 2026, 18:17 UTC

    Study results updated

  4. Version 1

    9 Oct 2026, 03:04 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.